Chemical Modification of Oligo(Hexamethylene Guanidine): Synthesis of Alkylated Derivatives and Their Estimated Activity Against Mycobacterium Smegmatis


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

It was found that oligo(hexamethylene guanidine) (OHMG) reacted very slowly with unactivated high-molecular-mass alkyl halides (dodecyl chloride), possibly due to steric hindrance and the low nucleophilicity of the guanidine moiety. Therefore, this alkyl halide could not be used to modify OHMG under conventional conditions. Ethylation of OHMG was much more facile. However, the substitution in the derivatives was broadly scattered (under ordinary conditions and reagent ratios). It was shown simultaneously that the antibacterial activity of the alkylated derivatives was less than that of the starting OHMG hydrochloride. Benzyl chloride reacted readily with OHMG to produce derivatives with the desired degree of substitution. It was found that benzyl derivatives with 0.2 degree of substitution were more active against mycobacteria than the starting hydrochloride with the activity gradually diminishing if the degree of substitution was increased further. The increased activity may have been related to the optimum increase of OHMG hydrophobicity and/or steric structure. The rather high antibacterial activities of the benzyl derivatives against Mycobacterium smegmatis strain ATCC 607 made them promising for further development and studies of the properties of alkylated OHMG derivatives to discover more active derivatives, including against M. smegmatis. The most obvious candidates could become the methylcarboxy-substituted OHMG derivatives.

Авторлар туралы

S. Kedik

Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University

Email: shatalov_d@mirea.ru
Ресей, 86 Prosp. Vernadskogo, Moscow, 119571

D. Shatalov

Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University

Хат алмасуға жауапты Автор.
Email: shatalov_d@mirea.ru
Ресей, 86 Prosp. Vernadskogo, Moscow, 119571

A. Askretkov

Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University

Email: shatalov_d@mirea.ru
Ресей, 86 Prosp. Vernadskogo, Moscow, 119571

P. Isaikina

Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University

Email: shatalov_d@mirea.ru
Ресей, 86 Prosp. Vernadskogo, Moscow, 119571

I. Sedishev

Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University

Email: shatalov_d@mirea.ru
Ресей, 86 Prosp. Vernadskogo, Moscow, 119571

A. Panov

Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University

Email: shatalov_d@mirea.ru
Ресей, 86 Prosp. Vernadskogo, Moscow, 119571

A. Evseeva

Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University

Email: shatalov_d@mirea.ru
Ресей, 86 Prosp. Vernadskogo, Moscow, 119571

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Springer Science+Business Media, LLC, part of Springer Nature, 2017